Cargando…
Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases
Efaproxiral (Efaproxyn™, RSR13), a synthetic allosteric modifier of haemoglobin (Hb), decreases Hb-oxygen (O(2)) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy. This analysis evaluated the Phase 3, Radiation Enhancing Allosteric Compound for Hypoxic Brain Metas...
Autores principales: | Stea, B, Shaw, E, Pintér, T, Hackman, J, Craig, M, May, J, Steffen, R P, Suh, J H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361352/ https://www.ncbi.nlm.nih.gov/pubmed/16773073 http://dx.doi.org/10.1038/sj.bjc.6603169 |
Ejemplares similares
-
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases
por: Queirolo, Paola, et al.
Publicado: (2014) -
Mapping distribution of brain metastases: does the primary tumor matter?
por: Schroeder, T., et al.
Publicado: (2020) -
The Measurement of Sodium Concentration in Human Red Blood Cells
por: Beilin, L. J., et al.
Publicado: (1966) -
Evaluation of the utility and accuracy of body fluids containing red blood cells to determine canine and feline blood types
por: Garcia‐Arce, Marta, et al.
Publicado: (2022) -
Metastatic melanoma: prognostic factors and survival in patients with brain metastases
por: Frinton, E., et al.
Publicado: (2017)